Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.

Revenue
+2.75%
EPS
−500.0%
Free cash flow
−60.6%
Total debt
+4.92%

Quarter to June 2026, against a year earlier

23.18 0.02 +0.09%
Market cap
$3.0B
P/E
0.0×
Fwd P/E
−35.3×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100

Surgery Partners, Inc. (SGRY) Revenue growth

Alert me on Revenue growth

Surgery Partners, Inc.'s revenue growth over the twelve months to 30 June 2026 was 3.99%, down 2.2 percentage points from fiscal 2025 (6.24%). Over the past ten years it has ranged from 1.57% (fiscal 2020) to 138.0% (fiscal 2015); the current reading is higher than 27% of that period. That is below the Medical Care Facilities industry median of 6.38% and below the Healthcare sector median of 7.80%.

Revenue growth, annual

Embed this chart

Annual newest first

Period Revenue growth Change (points)
FY2025 6.24% (7.28)
FY2024 13.5% 5.49
FY2023 8.03% (6.09)
FY2022 14.1% (5.50)
FY2021 19.6% 18.05
FY2020 1.57% (1.81)
FY2019 3.38% (28.70)
FY2018 32.1% 14.99
FY2017 17.1% (2.24)
FY2016 19.3% (118.69)

Quarterly newest first

Period Revenue growth Change (points)
Jun 2026 2.75% (1.75)
Mar 2026 4.50% 2.12
Dec 2025 2.38% (4.25)
Sep 2025 6.63% (1.78)
42 more quarters

Against its own ten years

Low 1.57% High 138.0%
Ten-year median 14.1%
Current reading's percentile 27

Revenue growth against peers

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on SGRY